REGN
Regeneron Pharmaceuticals, Inc.
Set alert
- YTD
- +20.21%
- 1 year
- +41.87%
- Open
- 869.43
- Prev close
- 818.77
- Mkt cap
- 95.53B
- Vol
- 2.85M
- Avg vol
- 707.20K
- EPS
- 40.44
- P/E
- 22.94
- Div yield
- 0.46%
More statistics
- Low
- 839.08
- High
- 935.34
- Forward P/E
- 14.74
- Beta
- 0.15
- Short ratio
- 2.78
- Inst. own
- 93.18%
- Dividend
- 3.76
- Ex-div date
- Aug 17, 2026
- Earnings
- Jan 29, 2027
- 50-d avg
- 791.28
- 200-d avg
- 736.67
- 1y target
- 869.07
Discussion (114)
Sign in to join the discussion
trading on your own is not advisable, for good returns trade with a pro like Laura Ben Wesley on ???????? with less capital make monthly profits, she helped me acquire $20K in two weeks, Message Laura Ben Wesley via her ????????+1(541)310-7087
$REGN its best time the get position, to the moon ! Great company
$REGN
Bernstein initiates Regeneron as outperform
Bernstein said the biotechnology company is “writing the next chapter of growth.
“We initiate coverage on Regeneron with an Outperform rating and $1,125 price target.”
$REGN ?BOOM ???
Fire all executive levels at the hyper corrupt FDA.
750+ sp tomorrow
$REGN Regeneron's (REGN) Wet AMD Study on High Dose Eylea Meets Goal
Sorrento therapeutics has a better option !
Smaller doses ! In phase 11 in the uK now .
$SRNE
$REGN Beast ?????